CORDIS
EU research results

CORDIS

English EN

Towards enduring mouse resources and services advancing research into human health and disease

Objective

The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse models for basic research of human health and disease, and to translate this knowledge into therapeutic approaches for the benefit of the European society.

The expanded INFRAFRONTIER2020 network, coordinated by the INFRAFRONTIER GmbH, includes 3 SMEs and is strategically responding to the INFRADEV3 call with aligned objectives to advance the long-term sustainability which are 1) development of business models and a stable legal framework; 2) raise awareness of the INFRAFRONTIER RI; 3) provide bespoke services aligned with user demands; 4) promote best practices in mouse phenogenomics; 5) enhance robustness of the INFRAFRONTIER IT infrastructure and use of the EMMA strain resource; and 6) improve business processes. Towards achieving these objectives key INFRAFRONTIER2020 project deliverables are:

• INFRAFRONTIER Business Plan2.0, and business models for all services
• Stable legal framework built on the INFRAFRONTIER legal entity
• INFRAFRONTIER annual stakeholder conferences
• Customised mouse model and secondary phenotyping pilot services
• INFRAFRONTIER advanced training schools in mouse phenogenomics
• Reengineered EMMA Database2.0 system
• Annotated mouse models of human diseases
• Quality management system for the legal entity

INFRAFRONTIER2020 will 1) enhance the sustainable operation of the INFRAFRONTIER RI; 2) continue to structure the ERA, 3) foster innovation, and 4) address major societal challenges in human health by customised service pilots supporting research into common and rare diseases. A sustainable INFRAFRONTIER RI will ensure the quality of deposited mice and support the reproducibility of biological results. Outreach efforts will raise awareness of resources and services and facilitate sustainable engagement with industry and global consortia such as the International Mouse Phenotyping Consortium
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

INFRAFRONTIER GMBH

Address

Ingolstadter Landstrasse 1
85764 Neuherberg

Germany

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 1 837 700

Participants (29)

Sort alphabetically

Sort by EU Contribution

Expand all

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

Germany

EU Contribution

€ 477 872,75

USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE

Czechia

EU Contribution

€ 195 528,13

OULUN YLIOPISTO

Finland

EU Contribution

€ 140 100

CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE

France

EU Contribution

€ 306 900

BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING

Greece

EU Contribution

€ 215 600

VETERINAERMEDIZINISCHE UNIVERSITAET WIEN

Austria

EU Contribution

€ 16 000

Toronto Centre for Phenogenomics Inc.

Canada

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 212 800

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Germany

EU Contribution

€ 12 800

MEDIZINISCHE HOCHSCHULE HANNOVER

Germany

EU Contribution

€ 17 600

TSE SYSTEMS GMBH

Germany

EU Contribution

€ 25 600

AYOXXA BIOSYSTEMS GMBH

Germany

EU Contribution

€ 20 800

KOBENHAVNS UNIVERSITET

Denmark

EU Contribution

€ 22 400

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 72 625

UNIVERSITAT AUTONOMA DE BARCELONA

Spain

EU Contribution

€ 12 800

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 96 460,31

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 69 773,91

INSTITUT PASTEUR

France

EU Contribution

€ 42 600

BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNAS KAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS

Greece

EU Contribution

€ 91 125

TEL AVIV UNIVERSITY

Israel

EU Contribution

€ 12 800

CONSIGLIO NAZIONALE DELLE RICERCHE

Italy

EU Contribution

€ 384 000

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS

Netherlands

EU Contribution

€ 114 750

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands

EU Contribution

€ 20 800

FUNDACAO CALOUSTE GULBENKIAN

Portugal

EU Contribution

€ 120 539,74

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 77 321,38

UNITED KINGDOM RESEARCH AND INNOVATION

United Kingdom

EU Contribution

€ 227 905,94

MEDICAL RESEARCH COUNCIL

United Kingdom

GENOME RESEARCH LIMITED

United Kingdom

EU Contribution

€ 69 875

THE UNIVERSITY OF SHEFFIELD

United Kingdom

EU Contribution

€ 40 800

Project information

Grant agreement ID: 730879

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2020

Funded under:

H2020-EU.1.4.1.1.

  • Overall budget:

    € 4 968 252,16

  • EU contribution

    € 4 955 877,16

Coordinated by:

INFRAFRONTIER GMBH

Germany